Leerink Partners Maintains Market Perform on Accendra Health, Lowers Price Target to $2.75
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Leerink Partners analyst Michael Cherny maintains Accendra Health (NYSE:ACH) with a Market Perform and lowers the price target from $3 to $2.75.
Leerink Partners analyst Michael Cherny maintains Accendra Health (NYSE:ACH) with a Market Perform and lowers the price target from $3 to $2.75.